% | $
Quotes you view appear here for quick access.

Regeneron Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • martian_65 martian_65 Feb 26, 2007 12:17 PM Flag

    Study finds drug Avastin helps brain tumors

    So how is this to be interpreted?

    On the positive side, I suppose, it further validates this type of therapy which is also the vegf trap approach.

    But, on the other hand, we have Avastin approved for three indications with vegf trap a number of years away from approval for one.

    Does this news in fact point to difficulty for the profitability of vegf trap?

    Not saying I know this, just asking the question.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I take it very positively. Validates where we are heading. Look at all the satins (Lipitor, Vitoren, Crestor etc... etc...) in the market and how they all make money and big money at that. We have a solution to not just one problem/disease but several. Everyone's body is a little different, so different drugs and or combinations of drugs will be more successful/effective in one case versus another.

513.88-2.12(-0.41%)May 22 3:59 PMEDT